Live Breaking News & Updates on Pharnext Sa Stock Exchange
Stay updated with breaking news from Pharnext sa stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DJ Pharnext: Findings on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A From 'Real-World' Digital Lifestyle Study, CMT&Me, to be Presented at the American Association of Neuromuscular & Electrodia ....
14.09.2022 - PARIS, FRANCE / ACCESSWIRE / September 14, 2022 / Pharnext SA (FR0011191287:ALPHA) (the Company ), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical need, . Seite 1 ....
Investegate announcements from Pharnext, Findings From ‘Real-World’ Digital Lifestyle Study, CMT&Me, on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A Published in the Journal of Clinical Neuromuscular Disease ....
Investegate announcements from Pharnext, Pharnext Announces First Patient Enrolled in Open Label Extension of the Pivotal Phase III Study of PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A, the PREMIER Trial ....